Global, Regional, and National Burden of Parkinson's Disease 1990–2021: A Systematic Analysis of the Global Burden of Disease Study 2021
Jiacheng Wang(Harbin Medical University), Yongshuai Jiang(Harbin Medical University), Siyu Wei(Harbin Medical University), Jing Xu(Harbin Medical University), Zhenwei Shang(Harbin Medical University), Hongchao Lv(Harbin Medical University), Wenhua Lv(Harbin Medical University), Ruilin Li(Harbin Medical University), Shuo Bi(Harbin Medical University), Xuying Guo(Harbin Medical University), Haiyan Chen(Renji Hospital), Chen Sun(Anhui Medical University), Linna Yuan(Harbin Medical University), Hao Tang(Central South University), Shuhao Zhang(Children's Hospital of Fudan University), Hongsheng Tian(Harbin Medical University), Yuping Zou(Harbin Medical University), Ruijie Zhang(Harbin Medical University), Mingming Zhang(Nanjing Medical University), Wei She(Harbin Medical University), Junxian Tao(Harbin Medical University)
Cited by 2
Related Papers
Association of inflammatory biomarkers with clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinoma
|Journal of Hepatology|2020|421
Global, regional, national burden of asthma from 1990 to 2021, with projections of incidence to 2050: a systematic analysis of the global burden of disease study 2021
|EClinicalMedicine|2025|135